{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:28Z","timestamp":1788922168445,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD028540"],"award-info":[{"award-number":["S10OD028540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000945","name":"Pittsburgh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS124730"],"award-info":[{"award-number":["R01-NS124730"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpet.2025.103645","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:19:19Z","timestamp":1750879159000},"page":"103645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic analysis of morphine-3-glucuronide after acute morphine intravenous bolus administration to rats with traumatic brain injury"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-6859","authenticated-orcid":false,"given":"Jonathan","family":"Birabaharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Henchir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Svirsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-1382","authenticated-orcid":false,"given":"Thomas D.","family":"Nolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-2339","authenticated-orcid":false,"given":"Philip E.","family":"Empey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-5075","authenticated-orcid":false,"given":"Shaun W.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103645_bib1","series-title":"National Center for Health Statistics: Mortality Data on CDC WONDER","year":"2023"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/HTR.0000000000000484","article-title":"Functional outcome trajectories following inpatient rehabilitation for TBI in the United States: a NIDILRR TBIMS and CDC Interagency Collaboration","volume":"35","author":"Dams-O\u2019Connor","year":"2020","journal-title":"J Head Trauma Rehabil"},{"issue":"7","key":"10.1016\/j.jpet.2025.103645_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002331","article-title":"Years of life lost due to traumatic brain injury in Europe: A cross-sectional analysis of 16 countries","volume":"14","author":"Majdan","year":"2017","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103645_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000431043","article-title":"Burden of traumatic brain injury in new zealand: incidence, prevalence and disability-adjusted life years","volume":"44","author":"Te Ao","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"S2","key":"10.1016\/j.jpet.2025.103645_bib5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/trf.15171","article-title":"Management of moderate and severe traumatic brain injury","volume":"59","author":"Abdelmalik","year":"2019","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/bja\/87.2.186","article-title":"Sedative and analgesic practice in the intensive care unit: the results of a European survey","volume":"87","author":"Soliman","year":"2001","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinane.2010.08.002","article-title":"Morphine and its metabolites after patient-controlled analgesia: considerations for respiratory depression","volume":"23","author":"Sam","year":"2011","journal-title":"J Clin Anesth"},{"issue":"9","key":"10.1016\/j.jpet.2025.103645_bib8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/dmd.31.9.1086","article-title":"Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7","volume":"31","author":"Stone","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.jpet.2025.103645_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11302-016-9525-4","article-title":"Morphine enhances IL-1\u03b2 release through toll-like receptor 4-mediated endocytic pathway in microglia","volume":"12","author":"Liang","year":"2016","journal-title":"Purinergic Signal"},{"issue":"10","key":"10.1016\/j.jpet.2025.103645_bib10","first-page":"2767","article-title":"Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-3806(91)90149-D","article-title":"Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation","volume":"60","author":"Stiene-Martin","year":"1991","journal-title":"Dev Brain Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.20892\/j.issn.2095-3941.2020.0442","article-title":"Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer","volume":"18","author":"Wang","year":"2021","journal-title":"Cancer Biol Med"},{"issue":"16","key":"10.1016\/j.jpet.2025.103645_bib13","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2025.103645_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbi.2016.12.002","article-title":"Activation of \u03bc-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice","volume":"61","author":"Xie","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103645_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1742-2094-9-200","article-title":"Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling","volume":"9","author":"Due","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jpet.2025.103645_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PCC.0b013e3181e8b32d","article-title":"Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum","volume":"12","author":"Fraser","year":"2011","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/NEN.0000000000000021","article-title":"Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation","volume":"73","author":"Loane","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103645_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/clpt.1985.204","article-title":"Pharmacokinetics of high-dose pentobarbital in severe head trauma","volume":"38","author":"Bayliff","year":"1985","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jpet.2025.103645_bib20","first-page":"459","article-title":"Pentobarbital pharmacokinetics in patients with severe head injury","volume":"21","author":"Wermeling","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1997.tb04771.x","article-title":"Effect of acute phase response on phenytoin metabolism in neurotrauma patients","volume":"37","author":"McKindley","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103645_bib22","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1007\/s12035-021-02534-3","article-title":"Reductions in synaptic vesicle glycoprotein 2 isoforms in the cortex and hippocampus in a rat model of traumatic brain injury","volume":"58","author":"Fronczak","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103645_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-3565(25)27063-X","article-title":"Some effects of morphine on respiration and metabolism of rats","volume":"148","author":"Kokka","year":"1965","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.jpet.2025.103645_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/laban.257","article-title":"Using anesthetics and analgesics in experimental traumatic brain injury","volume":"42","author":"Rowe","year":"2013","journal-title":"Lab Anim (NY)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.2510140102","article-title":"Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine","volume":"14","author":"Ekblom","year":"1993","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"10.1016\/j.jpet.2025.103645_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","article-title":"Randomized placebo-controlled trial of the activity of the morphine glucuronides","volume":"68","author":"Penson","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103645_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114853","article-title":"Simultaneous detection of a panel of nine sedatives and metabolites in plasma from critically ill pediatric patients via UPLC-MS\/MS","volume":"218","author":"Birabaharan","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jpet.2025.103645_bib28","series-title":"Rowland and Tozer\u2019s Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Derendorf","year":"2020"},{"key":"10.1016\/j.jpet.2025.103645_bib29","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"issue":"3","key":"10.1016\/j.jpet.2025.103645_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-0270(91)90104-8","article-title":"A controlled cortical impact model of traumatic brain injury in the rat","volume":"39","author":"Dixon","year":"1991","journal-title":"J Neurosci Methods"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0773.1996.tb00239.x","article-title":"Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat","volume":"79","author":"Hasselstr\u00f6m","year":"1996","journal-title":"Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1440-1681.2008.05019.x","article-title":"Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests","volume":"36","author":"South","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1 Pt 2","key":"10.1016\/j.jpet.2025.103645_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"10.1016\/j.jpet.2025.103645_bib34","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1208\/s12248-015-9792-y","article-title":"Effect of traumatic brain injury, erythropoietin, and anakinra on hepatic metabolizing enzymes and transporters in an experimental rat model","volume":"17","author":"Anderson","year":"2015","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.jpet.2025.103645_bib35","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.12998\/wjcc.v10.i9.2751","article-title":"Acute kidney injury in traumatic brain injury intensive care unit patients","volume":"10","author":"Huang","year":"2022","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib36","first-page":"1","article-title":"Evaluation of renal function in rats with moderate and mild brain trauma","volume":"28","author":"Tekin Neijmann","year":"2022","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088516","article-title":"P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac","volume":"9","author":"Sanchez-Covarrubias","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/neur.2020.0034","article-title":"P-glycoprotein expression is upregulated in a pre-clinical model of traumatic brain injury","volume":"1","author":"Vita","year":"2020","journal-title":"Neurotrauma Rep"},{"key":"10.1016\/j.jpet.2025.103645_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuropharm.2013.08.019","article-title":"In vitro morphine metabolism by rat microglia","volume":"75","author":"Togna","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(88)90219-9","article-title":"Human brain metabolism of morphine and naloxone","volume":"35","author":"Wahlstr\u00f6m","year":"1988","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.jpet.2025.103645_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bph.15792","article-title":"Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice","volume":"180","author":"Gabel","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"1-2","key":"10.1016\/j.jpet.2025.103645_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(95)01329-6","article-title":"Prolonged and extensive IgG immunoreactivity after severe fluid-percussion injury in rat brain","volume":"711","author":"Hoshino","year":"1996","journal-title":"Brain Res"},{"issue":"1-2","key":"10.1016\/j.jpet.2025.103645_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2014.08.626","article-title":"Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice","volume":"276","author":"Jeong","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jnr.24731","article-title":"Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes","volume":"100","author":"Dozio","year":"2022","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-4886(03)00002-5","article-title":"Time course of cellular pathology after controlled cortical impact injury","volume":"182","author":"Chen","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpet.2025.103645_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102136","article-title":"Evaluating spatiotemporal microstructural alterations following diffuse traumatic brain injury","volume":"25","author":"Mohamed","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"4","key":"10.1016\/j.jpet.2025.103645_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1523\/JNEUROSCI.4595-08.2009","article-title":"Morphine enhances microglial migration through modulation of P2X4 receptor signaling","volume":"29","author":"Horvath","year":"2009","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.jpet.2025.103645_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib49","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2009.10.011","article-title":"Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4\/MD-2 and interleukin-1beta","volume":"165","author":"Lewis","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpet.2025.103645_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.753570","article-title":"Determining sex-based differences in inflammatory response in an experimental traumatic brain injury model","volume":"13","author":"Scott","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103645_bib51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnmol.2012.00006","article-title":"The cytokine temporal profile in rat cortex after controlled cortical impact","volume":"5","author":"Dalgard","year":"2012","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103645_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.123.001664","article-title":"Recovery from traumatic brain injury is nociceptin\/orphanin FQ peptide receptor genotype-, sex-, and injury severity-dependent","volume":"389","author":"Al Yacoub","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.jpet.2025.103645_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cns.13655","article-title":"Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice","volume":"27","author":"Wang","year":"2021","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103645_bib54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12974-022-02643-3","article-title":"The dynorphin\/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma","volume":"19","author":"Lee","year":"2022","journal-title":"J Neuroinflam"},{"key":"10.1016\/j.jpet.2025.103645_bib55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2014.09.020","article-title":"Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae","volume":"280","author":"Grace","year":"2014","journal-title":"Neuroscience"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:15:10Z","timestamp":1756376110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0022356525398587"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103645","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic analysis of morphine-3-glucuronide after acute morphine intravenous bolus administration to rats with traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103645"}}